WELLS FARGO & COMPANY/MN - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 78 filers reported holding ATHIRA PHARMA INC in Q2 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q3 2023$25,920
-31.5%
12,832
-0.0%
0.00%
Q2 2023$37,861
-18.7%
12,834
-31.1%
0.00%
Q1 2023$46,590
+16.6%
18,636
+47.8%
0.00%
Q4 2022$39,974
+8.0%
12,610
-0.5%
0.00%
Q3 2022$37,000
-7.5%
12,677
-3.5%
0.00%
Q2 2022$40,000
-81.5%
13,138
-17.9%
0.00%
Q1 2022$216,000
-39.0%
16,007
-41.2%
0.00%
Q4 2021$354,000
+35300.0%
27,230
+27130.0%
0.00%
Q3 2021$1,000
-97.8%
100
-97.8%
0.00%
Q2 2021$46,000
-72.5%
4,578
-49.7%
0.00%
Q1 2021$167,000
-48.5%
9,106
-3.4%
0.00%
Q4 2020$324,0009,4280.00%
Other shareholders
ATHIRA PHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
VR Adviser, LLC 1,691,623$31,126,0003.38%
ACUTA CAPITAL PARTNERS, LLC 400,000$7,360,0002.65%
Logos Global Management LP 1,010,812$18,599,0001.82%
S Squared Technology, LLC 181,220$3,334,0001.58%
Avidity Partners Management LP 1,677,845$30,872,0000.85%
Perceptive Advisors 3,425,916$63,037,0000.80%
RTW INVESTMENTS, LP 2,652,553$48,807,0000.76%
Sofinnova Investments, Inc. 509,168$9,369,0000.56%
HighVista Strategies LLC 32,062$590,0000.44%
DAFNA Capital Management LLC 91,531$1,684,0000.40%
View complete list of ATHIRA PHARMA INC shareholders